WHA Side Event Explores Improving Access To Medicines, Roles Of Accountability, Transparency

Intellectual Property Watch: Expanding Access To Medicines: What Role For Transparency?
“…On Tuesday afternoon, those not busy casting a vote for the next World Health Organization director general got the chance to dig into [questions about transparency and accountability in global health] at a panel co-sponsored by the Graduate Institute [Global Health Centre] and FIND. In particular, discussion focused on transparency in terms of public access to two types of information: drug R&D costs and clinical trial data. … [D]iscussion quickly focused in on the role and responsibilities of the pharmaceutical industry…” (Pillinger, 5/25).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.